Both Blue Shield of California and Kaiser Permanente apply a BMI 40 weight-loss threshold for new GLP-1 starts since January 2025
Mechanism of Action Comparison# Retatrutide# Retatrutide (LY3437943) is a 39-amino acid peptide that simultaneously activates three metabolically important receptors: GLP-1 receptor : Enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes central satiety signaling GIP receptor : Potentiates insulin secretion, may improve beta-cell function, and contributes to adipose tissue metabolism Glucagon receptor : Increases hepatic glucose output acutely but chronically promotes hepatic fat oxidation, thermogenesis, and energy expenditure The glucagon receptor component distinguishes retatrutide from all other approved or late-stage metabolic peptides
Recognizing these distinctions helps inform confident ingredient selection
IIH can lead to permanent visual impairment or even blindness if left untreated [4]
Glutathione is produced naturally by the liver and is also found in many foods
Here, both Arg123 and Arg127 of semaglutides backbone (cyan cartoon, Figures 3, 4 and 5) formed interfacial salt bridges with Glu40 of GLP-1R ECD (green cartoon, Figures 3, 4 and 5), the details of which are included in Table 4 and shown in Figure 5